CLOVER HEALTH INVESTMENTS, CORP. /DE vs HUMANA INC, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CLOV and HUM diverge most: on net margin, CLOV reads -2.6% and HUM reads 0.8%; on return on equity, CLOV reads -16.8% and HUM reads 6.1%. The rest of the comparable metrics sit closer together. What CLOV's price implies is an extreme bet versus history and the cohort (earnings-power basis). What HUM's price implies is a bet that sits within the historical range. The bull and bear cases for each are in their full reports below.
| Metric | CLOV | HUM |
|---|---|---|
| Price | $4.16 | $363.85 |
| Market cap | $2.2B | $43.9B |
| Sector | Managed Care | Managed Care |
| Stage | Growth | Growth |
| P/B | 6.53 | 2.35 |
| P/S | 1.00 | 0.32 |
| EV/EBITDA | — | 16.5 |
| Revenue growth | +47.7% | +13.9% |
| Operating margin | 3.6% | 4.4% |
| Net margin | -2.6% | 0.8% |
| Return on equity | -16.8% | 6.1% |
| Return on assets | -8.2% | 2.0% |
| Return on invested capital | -13.3% | 5.9% |
| FCF yield | 2.5% | 2.9% |
| Dividend yield | — | 1.0% |
| Debt / equity | 0.00 | 0.75 |
| Current ratio | 1.33 | 1.77 |
| Altman Z (solvency) | 2.66 | 4.43 |
| Piotroski F (quality) | 8 / 9 | 8 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.